This column is a collaboration with DoubleBlind, a print magazine and media company at the forefront of the psychedelic movement. At this point, there’s no question: researchers, investors, and stakeholders agree that psychedelics will be legal as pharmaceuticals in the next decade. The FDA has already granted both MDMA, the …
Read More »